Literature DB >> 20183427

Sample size allocation to regions in a multiregional trial.

Hiroyuki Uesaka1.   

Abstract

The objective of a multiregional bridging trial is to show the efficacy of a drug in various global regions, and at the same time to evaluate the possibility of applying the overall trial results to each region. However, to apply overall results to a specific region, the result in that region should be consistent with either the overall results or the results of other regions. This article discusses methods of sample size allocation to regions by introducing statistical criteria for consistency between regional and overall results. Specifically, three rules of sample size allocation are discussed: (1) allocating equal size to all regions, (2) minimizing total sample size, and (3) minimizing the sample size of a specific region. Some total and regional sample sizes calculated under each allocation rule are illustrated.

Mesh:

Year:  2009        PMID: 20183427     DOI: 10.1080/10543400902963185

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  1 in total

1.  Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints.

Authors:  Wong-Shian Huang; Hui-Nien Hung; Toshimitsu Hamasaki; Chin-Fu Hsiao
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.